Pacira BioSciences, Inc. (PCRX)
Debt-to-capital ratio
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 778,348 | 870,130 | 775,010 | 730,408 | 619,688 |
| Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $778,348K)
= 0.00
The debt-to-capital ratio for Pacira BioSciences, Inc. has consistently been 0.00 from December 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt financing to fund its operations and growth during this period. A debt-to-capital ratio of 0.00 means that the company's total debt is not a component of its capital structure, reflecting a strong financial position with no debt burden. This may suggest that the company has been able to finance its operations through equity or retained earnings rather than taking on debt, which can be seen as a positive sign of financial stability and strength.
Peer comparison
Dec 31, 2024